Welcome to Bioscreen

Entrust your health and your results in our testing to restore your gut microbiota to a healthy pattern

Characterizing the gut microbiota is an important step towards improving overall health.

Why choose us

Bioscreen has been investigating the relationship between the gut 'microbiota' and health for over 30 years. We are the only laboratory in Australia that cultures all the significant live bacteria that can be recovered from your faecal sample. Our scientists are dedicated to improving the health and well-being of our patients.

How we can help

Do you suffer from fatigue or abdominal bloating? Do you suffer from digestive problems, alternating bowel motions, food sensitivities, poor sleep and concentration? Have you been diagnosed with fibromyalgia / CFS? Our extended faecal microbial analysis (FMA) test can investigate the composition of your microbiota. This information can help your health practitioner modify your gut microbiota to improve your health.

Faecal Microbial Analysis (FMA) Test

Faecal Microbial Analysis (FMA) Test

The FMA test analyses the gut microbiota using classical culture, and most up-to-date identification techniques.
Parasite Test

Parasite Test

Bioscreen use a two step Multiplexed Tandem PCR system for parasite testing.
Duodenal Aspirate Test

Duodenal Aspirate Test

The duodenal aspirate test analyses the microbiota of the upper small intestine.

The Gut Health Science Organisation


is launching in February 2022.

 

Dear Associate,

As you have previously been involved with, or taken an interest in, Bioscreen, we wanted to let you know about an important development in the field of gut health. The Gut Health Science Organisation has been founded by Dr Henry Butt (MSc, PhD) — Director of Bioscreen — and Dr Fi Lam (MHB (Imm), MBChB, DipSport Med, Cert Int Med (Qld), FRNZCGP, FRACGP, FACNEM) — a GP who has applied a lens of nutrition, genomics and deep listening to much of her practice over the years. We also have a Clinical Advisor with deep experience as a Director of Clinical Services — Dr Helena Johnston (MBBS, FACRRM, FRACMA, DipRCOG).

Why GHS?

The purpose of GHS is to provide evidence-based information on gut health through real-life case studies, ongoing research and continuing clinical application of new findings in the effects of microbiota on patient health.

GHS will create a knowledge bank that generates research funding — through learning modules and webinars — with the aim of increasing our understanding of how gut microbiota affect health and informing health professionals, along with the wider community, about better responses to gut health issues and nutrition.

If you'd like to be kept informed about our progress, please visit our landing page at https://www.guthealthscience.org to add your name to our list. We will never share your data or allow it to be used for any other purpose.

Thank you for your interest in Bioscreen, and we hope you can benefit from the work of the GHS.

 

Our Commitment to you

 

"Bioscreen is committed to the pursuit of excellence in microbiota testing using state of the art technology"

 

Read more